Authors:
ROSKROW MA
ROONEY CM
HESLOP HE
BRENNER MK
KRANCE RA
GRESIK MV
MCCLAIN K
AGUILAR LK
GRILLEY B
ROB E
CARRUM G
Citation: Ma. Roskrow et al., ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO PATIENTS WITH RELAPSED EBV-POSITIVE HODGKIN-DISEASE, Human gene therapy, 9(8), 1998, pp. 1237-1250
Authors:
ROONEY CM
SMITH CA
NG CYC
LOFTIN SK
SIXBEY JW
GAN YJ
SRIVASTAVA DK
BOWMAN LC
KRANCE RA
BRENNER MK
HESLOP HE
Citation: Cm. Rooney et al., INFUSION OF CYTOTOXIC T-CELLS FOR THE PREVENTION AND TREATMENT OF EPSTEIN-BARR VIRUS-INDUCED LYMPHOMA IN ALLOGENEIC TRANSPLANT RECIPIENTS, Blood, 92(5), 1998, pp. 1549-1555
Authors:
CHAN GCF
WANG WC
RAIMONDI SC
BEHM FG
KRANCE RA
CHEN G
FREIBERG A
INGRAM I
BUTLER D
HEAD DR
Citation: Gcf. Chan et al., MYELODYSPLASTIC SYNDROME IN CHILDREN - DIFFERENTIATION FROM ACUTE MYELOID-LEUKEMIA WITH A LOW BLAST COUNT, Leukemia, 11(2), 1997, pp. 206-211
Authors:
HONGENG S
KRANCE RA
BOWMAN LC
SRIVASTAVA DK
CUNNINGHAM JM
HORWITZ EM
BRENNER MK
HESLOP HE
Citation: S. Hongeng et al., OUTCOMES OF TRANSPLANTATION WITH MATCHED-SIBLING AND UNRELATED-DONOR BONE-MARROW IN CHILDREN WITH LEUKEMIA, Lancet, 350(9080), 1997, pp. 767-771
Authors:
KAUFFMAN WM
HESLOP HE
GRONEMEYER SA
CHEN G
KRANCE RA
Citation: Wm. Kauffman et al., HEPATIC ARTERIAL RESISTANCE INDEX - AN INDICATOR OF DIFFUSE LIVER-DISEASE IN CHILDREN TREATED WITH BONE-MARROW TRANSPLANTATION, Clinical Radiology, 52(12), 1997, pp. 903-906
Authors:
BENAIM E
KRANCE RA
RICHARDSON S
BOWMAN LC
SRIVASTAVA DK
CUNNINGHAM JM
HORWITZ EM
BRENNER MK
HESLOP HE
Citation: E. Benaim et al., COMPARISON OF OUTCOME OF ALLOGENEIC TRANSPLANTATION IN CHILDREN WITH LEUKEMIA USING UNRELATED DONORS OR MISMATCHED FAMILY MEMBER DONORS, Blood, 90(10), 1997, pp. 466-466
Authors:
HESLOP HE
NG CYC
LI CF
SMITH CA
LOFTIN SK
KRANCE RA
BRENNER MK
ROONEY CM
Citation: He. Heslop et al., LONG-TERM RESTORATION OF IMMUNITY AGAINST EPSTEIN-BARR-VIRUS INFECTION BY ADOPTIVE TRANSFER OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES, Nature medicine, 2(5), 1996, pp. 551-555
Authors:
HESLOP HE
BRENNER MK
KRANCE RA
BOWMAN L
CUNNINGHAM JM
RICHARDSON S
ALEXANDER B
HEIDEMAN R
BOYETT JM
MARCUS SG
BERENSON R
HEIMFELD S
BROWN S
Citation: He. Heslop et al., USE OF DOUBLE MARKING WITH RETROVIRAL VECTORS TO DETERMINE RATE OF RECONSTITUTION OF UNTREATED AND CYTOKINE EXPANDED CD34(-CELLS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION() SELECTED MARROW), Human gene therapy, 7(5), 1996, pp. 655-667
Authors:
KANE JR
HEAD DR
BALAZS L
HULSHOF MG
MOTRONI TA
RAIMONDI SC
CARROLL AJ
BEH FG
KRANCE RA
SHURTLEFF SA
DOWNING JR
Citation: Jr. Kane et al., MOLECULAR ANALYSIS OF THE PML RAR-ALPHA CHIMERIC GENE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA/, Leukemia, 10(8), 1996, pp. 1296-1302
Authors:
CELA ME
HOLLADAY MS
ROONEY CM
RICHARDSON S
ALEXANDER B
KRANCE RA
BRENNER MK
HESLOP HE
Citation: Me. Cela et al., GAMMA-DELTA T-LYMPHOCYTE REGENERATION AFTER T-LYMPHOCYTE-DEPLETED BONE-MARROW TRANSPLANTATION FROM MISMATCHED FAMILY MEMBERS OR MATCHED UNRELATED DONORS, Bone marrow transplantation, 17(2), 1996, pp. 243-247
Authors:
KAUFFMAN WM
HESLOP HE
GRONEMEYER SA
CHEN G
KRANCE RA
Citation: Wm. Kauffman et al., HEPATIC ARTERIAL RESISTANCE INDEX - SPECIFIC INDICATOR OF LIVER DYSFUNCTION IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION, Radiology, 201, 1996, pp. 998-998
Authors:
WINERMURAM HT
GURNEY JW
BOZEMAN PM
KRANCE RA
Citation: Ht. Winermuram et al., PULMONARY COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION, The Radiologic clinics of North America, 34(1), 1996, pp. 97
Authors:
BEHM FG
RAIMONDI SC
RIBEIRO RC
HEAD DR
KRANCE RA
Citation: Fg. Behm et al., ACUTE MYELOID LEUKEMIAS (AML) OTHER THAN AML-M5 AND AML-M4 SUBTYPES CAN HAVE MLL GENE REARRANGEMENTS WITHOUT CYTOGENETIC EVIDENCE OF A CHROMOSOME 11Q23 ABNORMALITY, Laboratory investigation, 74(1), 1996, pp. 621-621
Authors:
RODMAN JH
TONDA ME
STRICKLIN LJ
HESLOP HE
KRANCE RA
Citation: Jh. Rodman et al., INDUCTION OF HEPATIC DRUG-METABOLISM DURING HIGH-DOSE PREPARATIVE CHEMOTHERAPY FOR BONE-MARROW (BMT), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 36-36
Authors:
HONGENG S
KRANCE RA
BOWMAN LC
SRIVASTAVA DK
CUNNINGHAM JM
HORWITZ EM
BRENNER MK
HESLOP HE
Citation: S. Hongeng et al., IDENTICAL OUTCOMES OF ALLOGENEIC MATCHED SIBLING (MSD) AND UNRELATED DONOR (MUD) TRANSPLANTATION IN CHILDREN WITH LEUKEMIA, Blood, 88(10), 1996, pp. 1926-1926
Authors:
HESLOP HE
SMITH CA
NG C
LOFTIN SK
SIXBEY J
KRANCE RA
BRENNER MK
ROONEY CM
Citation: He. Heslop et al., EFFICACY OF ADOPTIVELY TRANSFERRED VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) FOR PROPHYLAXIS AND TREATMENT OF EBV LYMPHOMA, Blood, 88(10), 1996, pp. 2713-2713
Authors:
ROONEY CM
SMITH CA
NG CY
LOFTIN SK
LI C
KRANCE RA
BRENNER MK
HESLOP H
Citation: Cm. Rooney et al., GENETICALLY MARKED VIRUS-SPECIFIC CTLS TO CONTROL EBV-RELATEE LYMPHOPROLIFERATION, Experimental hematology, 23(8), 1995, pp. 851-851
Authors:
KAUFFMAN WM
ZUCKERMAN SL
HESLOP HE
KRANCE RA
Citation: Wm. Kauffman et al., PORTAL VENOUS DOPPLER FINDINGS IN A BONE-MARROW TRANSPLANT PATIENT WITH CARDIAC-TAMPONADE, Journal of ultrasound in medicine, 14(11), 1995, pp. 877-879
Authors:
HESLOP HE
BENAIM E
BRENNER MK
KRANCE RA
STRICKLIN LM
ROCHESTER RJ
BILLING R
Citation: He. Heslop et al., RESPONSE OF STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE TO LYMPHOBLAST ANTIBODY CBL1, Lancet, 346(8978), 1995, pp. 805-806
Authors:
ROONEY CM
SMITH CA
NG CYC
LOFTIN S
LI CF
KRANCE RA
BRENNER MK
HESLOP HE
Citation: Cm. Rooney et al., USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION, Lancet, 345(8941), 1995, pp. 9-13